Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Value of Glucose Monitoring for Non-insulin Using Diabetes Patients?
Posted: Saturday, July 07, 2007
A new study published on bmj.com questions the value of blood glucose monitoring among patients with well-controlled, non-insulin dependent (type 2) diabetes.

Teach Doctors To Cook And Walk
Posted: Saturday, July 07, 2007
Walk two miles and call me in the morning. That's what doctors could soon prescribe if the new leaders of two major medical groups have their way.

Rosiglitazone Debated at ADA Meeting
Posted: Saturday, July 07, 2007
They were waiting in a long line outside the hall to see Dr Steven Nissen (Cleveland Clinic, OH). He arrived to a packed auditorium to tell the audience what he knew about rosiglitazone (Avandia, GlaxoSmithKline), when he knew it, and what he believes needs to be done next.

Diabetes Prevalence Shows No Signs of Slowing
Posted: Saturday, June 30, 2007
The prevalence of diabetes of all types in the U.S. has risen by about 5% annually since 1990, keeping pace with the fattening of America, reported CDC investigators.

The Death of the A1c Test Results - Coming Soon Average Blood Glucose
Posted: Saturday, June 30, 2007
After the first of the year, the A1c results will probably get reported to patients as an average blood glucose. Will this will help the 75% of diabetics who don't know what an A1c test is?

New Class of Diabetes Drugs Effective in Controlling Blood Glucose
Posted: Saturday, June 30, 2007
First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes.

Statins and Fibrates Prevents Diabetic Neuropathy by 48%
Posted: Saturday, June 30, 2007
A major epidemiological study conducted over eight years in Australia has shown that two classes of lipid-lowering drugs - statins and fibrates - significantly lower the risk of developing nerve damage known as peripheral sensory diabetic neuropathy.

New Drug Cycloset Improves Glucose Control and Reduces CVD Risk
Posted: Saturday, June 30, 2007
A quick release formulation of bromocriptine mesylate in patients with type 2 diabetes improves glycemic control and reduces diabetic cardiovascular complications.

Diabetes a Risk Factor for Cardiovascular Morbidity and Mortality in 3.3 Million Subjects
Posted: Saturday, June 30, 2007
A new study concludes that patients with type 2 diabetes 30 years of age and older who are receiving glucose-reducing treatment should also receive prompt intensive prophylactic treatment for cardiovascular disease.

Once Weekly Dosing GLP-1 Promotes Beta-Cell Growth
Posted: Saturday, June 30, 2007
Preclinical data suggests a long-acting formulation of native, human GLP-1 can promote the growth of insulin producing cells (beta cells) in a type 1 diabetes animal model.

Page 209 of 399
 |<   <<   <  204  |  205  |  206  |  207  |  208  |  209  |  210  |  211  |  212  |  213  |  214  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement